White Paper
How Life Sciences Companies Can Build Resilience Amid Economic and Geopolitical Volatility
White Paper Summary
The life sciences industry has entered a new era of economic and geopolitical uncertainty. The drumbeat of stiff tariffs, evolving trade routes, and shifting supply chain priorities are forcing companies to rethink how they operate, source materials, and deliver products to market. For an industry that depends heavily on cross-border trade for both inputs and finished goods, these forces are creating unprecedented complexity.
At the same time, the pace of change is accelerating. A single trade restriction can send ripples through global supply networks, affecting where companies source parts, how they ship products, and how they reach the end user. For insurers underwriting life sciences risk, understanding these interconnected exposures has never been more important because economic pressures can fundamentally change how companies operate.
“We’re clearly in a new era for international trade, with the reality that trade is evolving and adding risk and uncertainty to the economy,” said Ben Wright, Head of The Hartford’s Global Insights Center.
To learn more about The Hartford, please visit their website.


